We hope your year is off to a good start. At Akron Biotech, we’ve been busy—manufacturing cGMP ancillary materials, growing our team, developing our product lines, and collaborating on exciting developments in regenerative medicine. We have a number of upcoming events, and we can’t wait to connect with you.
Spotlight: cGMP Recombinant Cytokines and Growth Factors
The quality of cytokines and growth factors is critical to a cell or gene therapy’s ultimate success. At Akron, we take an orthogonal approach to protein purification, which ultimately produces clean, high-quality proteins.
Our cGMP cytokines feature:
·ISO-Certified cGMP production with quality-controlled materials
In the rapidly developing industry of advanced therapies, the quality and consistency of ancillary materials take center stage when considering the drug manufacturer’s cost control and the ultimate quality of the end therapy.
It is our responsibility as ancillary suppliers to take the initial steps in reducing the inherent variability within our industry. Find out some of the ways Akron measures variation in cytokines.
XTalks Webinar: De-risking the Manufacturing of Cell Therapies through Virus-Inactivated Products
Akron Biotech Vice President of Global Sales Robert Margolin, SCB President and ARMI Chief Regulatory Officer Richard McFarland, and Adaptimmune Associate Director of Process Sciences Raymond Luke will discuss strategies for how to ensure the integrity of ancillary materials in the manufacture of advanced therapy products.